# Baisheng (Guangzhou) Biological Products

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/baisheng-guangzhou-biological-products

- Industry: Healthcare
- Headquarters: Guangzhou, China
- Website: www.baisheng-gz.com
- Total disclosed funding: $1.4M
- Latest round: Angel (Jun 5, 2020)
- Investors on record: 2

## About

Based in Guangzhou, China and established in 2018, Baisheng (Guangzhou) Biological Products operates as a cancer diagnosis technology developer which focuses on immunity, molecular science and gene. The core team all have 5-10 years of experience in the pathology industry. The company's chairman and general manager, Tan Rui Zheng, has a PhD in management from Toulouse Business School in France and has worked for BAXTER, GSK and Yuanda Pharmaceuticals. This company developed the fully automated immunohistochemical stainer BMark™ in 2020 and completed the development of the double-layer chromosome all-in-one machine in 2021. It has been obtained 389 related product registrations as of 2022.

The company self-developed products such as automatic immunohistochemical stainer, HE HD dip stainer, special stainer, multimeric enzyme-labeled secondary antibody and monoclonal cell line. Their products are used in the field of iummunohistochemistry, molecular pathology and genetic diagnosis.

## Funding rounds

- Angel, Jun 5, 2020, $1.4M — Zhongda Venture Capital, Yanghe Biomedicine Industry Investment

## Investors

- Zhongda Venture Capital (https://capitalatlas.ai/funds/zhongda-venture-capital) — Angel
- Yanghe Biomedicine Industry Investment (https://capitalatlas.ai/funds/yanghe-biomedicine-industry-investment) — Angel